(#) We have performed a gait analysis service for the National Alkaptonuria Centre (NAC) since the summer of 2013 and have been involved in the DevelopAKUre trials since 2014. The service has become a well-oiled machine with patients attending every month to our Movement Function Research L.. ...more
I have been involved with the AKU projects here at Liverpool University since 2006 when Professor Ranganath first contacted Jim Gallagher about possible research on AKU. My first task was to show Laura Tinti how to culture osteoarticular cells when she came to our laboratory in 2006 on an E.. ...more
My name is Dr Peter Wilson and I am a postdoctoral research assistant at the University of Liverpool. I have been working on various AKU projects now for nearly 10 years, from the development of an in vitro model of AKU, to gene replacement therapy. One aspect of my job requires me to collect th.. ...more
Nordic Bioscience is a partner in the DevelopAKUre consortium. Nordic Bioscience (http://www.nordicbioscience.com/) is a Danish biotechnology company that specialises in biomarker research. They develop tools to measure specific substances in blood and urine. These substances are indicative of a.. ...more
DevelopAKUre is a series of major international clinical trials, run by a consortium of 12 European partners. It aims to study a potential new drug, called nitisinone, and assess its potential effectiveness in treating the rare disease, alkaptonuria (AKU).
DevelopAKUre is co-funded by a grant from the European Commission. This website is run by a UK patient group, the AKU Society. Learn more about AKU on the AKU Society's What is AKU page.
In today’s blog Chief investigator Prof. Ranganath reinforces the need for SONIA 2 pat.. ...more